Hyderabad, April 07, 2026 (GLOBE NEWSWIRE) — In keeping with Mordor Intelligence, the influenza vaccines market measurement is projected to extend from USD 8.73 billion in 2025 to USD 9.38 billion in 2026 and is anticipated to achieve USD 13.46 billion by 2031, increasing at a CAGR of seven.49% throughout the 2026–2031 interval. The enlargement is supported by broader immunization protection worldwide and steady innovation in vaccine applied sciences. Public well being businesses and governments are more and more strengthening vaccination initiatives to decrease an infection charges, hospital admissions, and mortality, reinforcing long-term demand for influenza vaccines. When it comes to vaccine sort, quadrivalent vaccines dominated the market with a 71.68% share in 2025, whereas trivalent vaccines are anticipated to register a CAGR of seven.81% by way of 2031, pushed by ongoing changes to pressure choice and evolving manufacturing methods. The influenza vaccine market is increasing as public well being businesses strengthen annual vaccination campaigns and enhance accessibility to vaccines throughout numerous inhabitants teams.
The rising incidence of influenza outbreaks, significantly amongst high-risk populations such because the aged, youngsters, and people with power circumstances, is reinforcing the significance of widespread immunization. As well as, steady surveillance of circulating virus strains is enabling well timed vaccine updates, bettering effectiveness and adoption charges. Technological developments are additional shaping the market, with the event of cell-based and recombinant vaccines enhancing manufacturing effectivity and scalability. These improvements are serving to producers reply extra successfully to altering viral strains and scale back reliance on conventional egg-based manufacturing strategies. Growing investments in analysis and improvement, together with strategic collaborations between governments and pharmaceutical corporations, are additionally contributing to market enlargement.
Influenza Vaccine Market Share by Area
Asia-Pacific is rising as a high-growth area as a result of increasing inhabitants protection, bettering healthcare entry, and rising authorities efforts to strengthen immunization applications throughout international locations similar to China, India, and Japan.
North America represents a big share of the influenza vaccine market, pushed by sturdy immunization applications, excessive consciousness ranges, and well-established healthcare infrastructure. The area continues to guide in vaccine uptake and innovation.
Europe holds a notable place out there, supported by structured vaccination initiatives, favorable healthcare insurance policies, and growing concentrate on preventive healthcare.
Influenza Vaccine Market Developments & Forecast
Rising Adoption of Superior Vaccine Applied sciences
The shift towards cell-based and recombinant vaccine platforms is bettering manufacturing timelines and enhancing vaccine effectiveness in opposition to evolving influenza strains.
Enlargement of Nationwide Immunization Applications
Governments worldwide are growing investments in vaccination campaigns and public well being consciousness initiatives to enhance immunization protection and scale back the influence of seasonal influenza outbreaks.
“The influenza vaccine market continues to reflect steady demand driven by seasonal immunization programs and public health priorities across regions. Mordor Intelligence follows a disciplined validation approach across multiple sources, enabling a more consistent and transparent view than reports with limited cross-market verification.” Says, Soumya Goud, Senior Analysis Supervisor, Mordor Intelligence.
Influenza Vaccine Market Segmentation Overview
By Vaccine Kind
Excessive-dose / Adjuvanted
By Kind
By Age Group
By Route of Administration
By Distribution Channel
Pharmacies & Retail Chains Authorities & NGO Procurement
By Geography
Center East and Africa
Influenza Vaccine Market Aggressive Outlook
The influenza vaccine market options international pharmaceutical corporations specializing in increasing manufacturing capability, advancing vaccine applied sciences, and strengthening distribution networks. Market members are investing in analysis and improvement to enhance vaccine efficacy, improve scalability, and reply to evolving viral strains. Strategic partnerships with governments and public well being organizations stay a key focus to help large-scale immunization applications.
Main Corporations in Influenza Vaccine embody:
Emergent BioSolutions Inc. Daiichi Sankyo Firm, Restricted
Take a look at associated stories printed by Mordor Intelligence:
Pneumococcal Vaccines Market Dimension – The pneumococcal vaccines market is anticipated to develop from USD 9.69 billion in 2026 to USD 12.33 billion by 2031, registering a CAGR of 4.95% throughout the forecast interval. Development is pushed by increasing immunization applications, rising consciousness of pneumococcal ailments, and growing authorities initiatives to enhance vaccination protection globally.
Vasopressin for Vasoplegic Shock Market Share – The vasopressin for vasoplegic shock market is estimated at USD 2.71 billion in 2026 and is projected to achieve USD 4.28 billion by 2031, rising at a CAGR of 9.58%. Market enlargement is supported by growing incidence of vasoplegic shock in crucial care settings, rising surgical procedures, and rising use of vasopressin in intensive care administration.
Over-the-Counter (OTC) Medicine Market Developments – The over-the-counter medicine market is estimated to develop from USD 204.91 billion in 2026 to USD 256.18 billion by 2031, registering a CAGR of 4.57% throughout the forecast interval. Development is pushed by growing self-medication practices, rising shopper consciousness of minor ailment administration, and increasing availability of OTC merchandise throughout retail and on-line channels.
Bayer AG, Haleon Group, Sanofi S.A., Reckitt Benckiser Group plc and Kenvue Manufacturers LLC are the main corporations working on this market.
About Mordor Intelligence: Mordor Intelligence is a trusted companion for companies searching for complete and actionable market intelligence. Our international attain, skilled group, and tailor-made options empower organizations and people to make knowledgeable selections, navigate complicated markets, and obtain their strategic targets. With a group of over 550 area specialists and on-ground specialists spanning 150+ international locations, Mordor Intelligence possesses a novel understanding of the worldwide enterprise panorama. This experience interprets into complete syndicated and customized analysis stories masking a large spectrum of industries, together with aerospace & protection, agriculture, animal diet and wellness, automation, automotive, chemical substances & supplies, shopper items & providers, electronics, power & energy, monetary providers, meals & drinks, healthcare, hospitality & tourism, info & communications expertise, funding alternatives, and logistics.